HEXPOL (STO:HPOL B) Full Year 2023 Results
Key Financial Results
- Revenue: kr22.0b (flat on FY 2022).
- Net income: kr2.52b (up 1.7% from FY 2022).
- Profit margin: 11% (in line with FY 2022).
- EPS: kr7.33 (up from kr7.21 in FY 2022).
All figures shown in the chart above are for the trailing 12 month (TTM) period
HEXPOL EPS Misses Expectations
Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 3.6%.
The primary driver behind last 12 months revenue was the HEXPOL Compounding segment contributing a total revenue of kr21.2b (96% of total revenue). Notably, cost of sales worth kr17.2b amounted to 78% of total revenue thereby underscoring the impact on earnings. The most substantial expense, totaling kr1.14b were related to Non-Operating costs. This indicates that a significant portion of the company's costs is related to non-core activities. Explore how HPOL B's revenue and expenses shape its earnings.
Looking ahead, revenue is forecast to grow 2.1% p.a. on average during the next 3 years, compared to a 6.0% growth forecast for the Chemicals industry in Sweden.
Performance of the Swedish Chemicals industry.
The company's shares are up 4.2% from a week ago.
Balance Sheet Analysis
While it's very important to consider the profit and loss statement, you can also learn a lot about a company by looking at its balance sheet. See our latest analysis on HEXPOL's balance sheet health.
Valuation is complex, but we're helping make it simple.
Find out whether HEXPOL is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.
View the Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About OM:HPOL B
HEXPOL
HEXPOL AB (publ) engages in development, manufacture, and sale of various polymer compounds and engineered products in Sweden, Europe, the Americas, and Asia.
Flawless balance sheet established dividend payer.